Table 3.
HRV species with associated clinical features.
| A (no. = 8) | B (no. = 2) | C (no. = 9) | Total (no. = 19) | ||
|---|---|---|---|---|---|
| Demographics | Male:female | 7:1 | 1:1 | 7:2 | 15:4 |
| Median age years (range) | 63 (33–65) | 37 (21–52) | 24 (18–63) | 39 (18–65) | |
| Graft type | Allogeneic recipient | 5 | 2 | 8 | 15 |
| Donor | Related donor | 2 | 2 | 1 | 5 |
| Unrelated donor | 3 | 0 | 7 | 10 | |
| Acquisition | Pre or during HSCT admission | 3 | 1 | 3 | 7 |
| During conditioning or <100 days | 3 | 1 | 7 | 11 | |
| Nosocomial acquisition | 2 | 1 | 5 | 8 | |
| Clinical illness | Asymptomatic | 1 | 0 | 1 | 2 |
| URTI | 4 | 0 | 3 | 7 | |
| LRTI | 2 | 1 | 3 | 6 | |
| U&LRTI | 1 | 1 | 2 | 4 | |
| All LRTI | 3 | 2 | 5 | 10 | |
| No LRTI | 5 | 0 | 4 | 9 | |
| Wheeze | 0 | 1 | 2 | 3 | |
| Co-pathogen | 3 | 1 | 4 | 8 | |
| Co-viruses | 3 | 0 | 3 | 6 | |
| Outcomes | Respiratory support | 0 | 2 | 2 | 4 |
| Fatal outcome | 0 | 0 | 1 | 1 |
Nosocomial acquisition – onset following four or more days of hospitalization.